Caitlin Reichert studied Life Sciences at the Hogeschool Utrecht, where she graduated in July 2021. In her last year she was an intern at the Den Boer group, where she investigated characteristics of the leukemic niche together with postdoc Cesca van de Ven. Now she is a research technician within the Den Boer group.
As technician she works on drug sensitivity tests and the iTHER (individualized therapy) program. The aim of performing drug screens is to get insight into which drugs will be beneficial to an individual patient.